F. Pons‐Romero

2.7k total citations · 1 hit paper
61 papers, 2.1k citations indexed

About

F. Pons‐Romero is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, F. Pons‐Romero has authored 61 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 31 papers in Hepatology and 20 papers in Surgery. Recurrent topics in F. Pons‐Romero's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (13 papers). F. Pons‐Romero is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatitis C virus research (15 papers) and Hepatitis B Virus Studies (13 papers). F. Pons‐Romero collaborates with scholars based in Spain, United Kingdom and China. F. Pons‐Romero's co-authors include Javier Crespo, Fernando Casafont, Emilio Fábrega, Amalía Cayón, Manuel Hernández‐Guerra, Pedro Fernández-Gil, Agustín Domínguez‐Díez, Antonio Cuadrado, Montserrat Rivero and Marta Mayorga and has published in prestigious journals such as Hepatology, Gut and Journal of Hepatology.

In The Last Decade

F. Pons‐Romero

61 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

2001 552 citations Javier Crespo, Amalía Cayón et al. profile →

Peers

Countries citing papers authored by F. Pons‐Romero

Since Specialization

Citations

This map shows the geographic impact of F. Pons‐Romero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Pons‐Romero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Pons‐Romero more than expected).

Fields of papers citing papers by F. Pons‐Romero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Pons‐Romero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Pons‐Romero. The network helps show where F. Pons‐Romero may publish in the future.

Co-authorship network of co-authors of F. Pons‐Romero

This figure shows the co-authorship network connecting the top 25 collaborators of F. Pons‐Romero. A scholar is included among the top collaborators of F. Pons‐Romero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Pons‐Romero. F. Pons‐Romero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Interleukin-9 in Stable Liver Transplant Recipients 2012 ·Transplantation Proceedings ·Emilio Fábrega, Marcos López‐Hoyos, David San Segundo, Fernando Casafont, (unknown), (unknown), F. Pons‐Romero	10
2	Chemoprophylaxis with isoniazid in liver transplant recipients 2012 ·Liver Transplantation ·Emilio Fábrega, (unknown), Joaquín Cabezas, Fernando Casafont, (unknown), (unknown), Javier Crespo, F. Pons‐Romero	26
3	Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis 2007 ·Obesity Surgery ·Armando Ruiz, Fernando Casafont, Javier Crespo, Amalía Cayón, Marta Mayorga, Á. Estébanez, (unknown), F. Pons‐Romero	211
4	Osteoprotegerin and receptor activator of nuclear factor‐κB ligand system in the early post‐operative period of liver transplantation 2006 ·Clinical Transplantation ·Emilio Fábrega, Aitor Orive, Maria Teresa Garcı́a-Unzueta, José Amado, Fernando Casafont, F. Pons‐Romero	13
5	Osteoprotegerin and RANKL in alcoholic liver cirrhosis 2005 ·Liver International ·Emilio Fábrega, Aitor Orive, (unknown), Maria Teresa Garcı́a-Unzueta, José Amado, F. Pons‐Romero	41
6	Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease 2005 ·Liver Transplantation ·Antonio Cuadrado, Emilio Fábrega, Fernando Casafont, F. Pons‐Romero	177
7	Serum Immunological Profile in Patients with Chronic Autoimmune Cholestasis 2004 ·The American Journal of Gastroenterology ·Manuel Romero‐Gómez, I. Wichmann, Javier Crespo, Albert Parés, Luı́s Rodrigo, (unknown), M. Diago, F. Pons‐Romero, (unknown), J. Aguilar‐Reina, Raúl J. Andrade, (unknown), Pilar Cubiles Sánchez-Pobre, (unknown), R Martín-Vivaldi, (unknown), Antonio Núñez‐Roldán, Miquel Bruguera, (unknown)	15
8	Fiebre, dolor en hipocondrio derecho y masa hepática con calcificación central 2004 ·Revista Española de Enfermedades Digestivas ·Antonio Cuadrado, Javier Crespo, José Luis Cabriada, F. Pons‐Romero	1
9	Triple terapia inmunosupresora en el tratamiento de la colitis ulcerosa grave 2004 ·Gastroenterología y Hepatología ·Beatriz Castro, Javier Crespo, (unknown), Emilio Fábrega, Fernando Casafont, F. Pons‐Romero	4
10	Apoptosis mediated by the Fas system in the fulminant hepatitis by hepatitis B virus 2002 ·Journal of Viral Hepatitis ·Montserrat Rivero, Javier Crespo, Emilio Fábrega, Fernando Casafont, (unknown), Manuel Gómez‐Fleitas, F. Pons‐Romero	51
11	Involvement of the Fas system in liver allograft rejection 2002 ·The American Journal of Gastroenterology ·Montserrat Rivero, Javier Crespo, (unknown), Emilio Fábrega, Fernando Casafont, F. Pons‐Romero	26
12	Plasma Leptin and TNF-α Levels in Chronic Hepatitis C Patients and Their Relationship to Hepatic Fibrosis 2002 ·Digestive Diseases and Sciences ·Javier Crespo, Montserrat Rivero, Emilio Fábrega, Amalía Cayón, José Amado, (unknown), F. Pons‐Romero	70
13	Dendroaspis natriuretic peptide in hepatic cirrhosis 2001 ·The American Journal of Gastroenterology ·Emilio Fábrega, Javier Crespo, Montserrat Rivero, Fernando Casafont, Beatriz Castro, Maria Teresa Garcı́a-Unzueta, José Amado, F. Pons‐Romero	3
14	Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial 1999 ·Gastrointestinal Endoscopy ·(unknown), Montserrat Rivero, Eloy Sánchez, Emilio Fábrega, Javier Crespo, F. Pons‐Romero	82
15	Severe clinical course of de novo hepatitis B infection after liver transplantation 1999 ·Liver Transplantation and Surgery ·Javier Crespo, Emilio Fábrega, Fernando Casafont, Montserrat Rivero, (unknown), Joaquín de la Peña, Fernando de la Cruz, F. Pons‐Romero	40
16	Value of endothelin in cellular rejection after liver transplantation 1997 ·Clinical Transplantation ·Emilio Fábrega, J. Figols, Carmen Dueñas, Javier Crespo, Fernando Casafont, Gloria Sánchez‐Antolín, (unknown), José Amado, F. Pons‐Romero	4
17	Nitric oxide production in hepatic cell rejection of liver transplant patients 1997 ·Transplantation Proceedings ·Emilio Fábrega, Fernando Casafont, Joaquín de la Peña, José R. Berrazueta, (unknown), J.A. Amado, F. Pons‐Romero	5
18	Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. 1994 ·PubMed ·Javier Crespo, Juanita Lozano, Fernando de la Cruz, Luı́s Rodrigo, Manuel Rodríguez, (unknown), Edurne Artiñano, F. Pons‐Romero	128
19	Hepatitis B virus replication in hepatitis B and D coinfection 1989 ·Liver International ·(unknown), Fernando de la Cruz, (unknown), S Echevarrı́a, (unknown), F. Pons‐Romero	10
20	The epidemiological importance of `ay' and `ad' subtypes of the HB-Ag 1974 ·Gut ·F. Pons‐Romero, Jenny Heathcote, S Sherlock	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact